Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Dexamethasone in Total Hip Arthroplasty
NCT04317872Completed
- Sponsor
- UZ Leuven
- Start
- Jul 2020
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in hip osteoarthritis and avascular necrosis of the hip (AVN) (2 arms), sponsored by UZ Leuven. Primary endpoint: Number of steps at 6 weeks. Started Jul 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
hip osteoarthritisavascular necrosis of the hip (AVN)
Beyond the preview
Go deeper on NCT04317872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04317872.